These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24825983)

  • 41. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
    Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Three-dimensional QSAR using the k-nearest neighbor method and its interpretation.
    Ajmani S; Jadhav K; Kulkarni SA
    J Chem Inf Model; 2006; 46(1):24-31. PubMed ID: 16426036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D-QSAR studies on a series of 5-arylidine-2, 4-thiazolidinediones as aldose reductase inhibitors: a self-organizing molecular field analysis approach.
    Thareja S; Aggarwal S; Bhardwaj TR; Kumar M
    Med Chem; 2010 Jan; 6(1):30-6. PubMed ID: 20402658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics.
    Wang F; Li Y; Ma Z; Wang X; Wang Y
    J Mol Model; 2012 Jan; 18(1):295-306. PubMed ID: 21523548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A structure-activity relationship study of imidazole-5-carboxylic acids derivatives as angiotensin II receptor antagonists combining 2D and 3D QSAR methods.
    Sharma MC
    Interdiscip Sci; 2014 Sep; ():. PubMed ID: 25183352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
    Kale MA; Sonwane GM
    Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of inhibitory activity of epidermal growth factor receptor inhibitors using grid search-projection pursuit regression method.
    Du H; Hu Z; Bazzoli A; Zhang Y
    PLoS One; 2011; 6(7):e22367. PubMed ID: 21811593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2D QSAR and Virtual Screening based on Pyridopyrimidine Analogs of Epidermal Growth Factor Receptor Tyrosine Kinase.
    Sugunakala S; Selvaraj S
    Curr Comput Aided Drug Des; 2016; 12(3):229-240. PubMed ID: 27264509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of various benzodiazepine analogues of gamma-secretase inhibitors.
    Sammi T; Silakari O; Ravikumar M
    J Mol Model; 2009 Apr; 15(4):343-8. PubMed ID: 19067000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.
    Zhao M; Wang L; Zheng L; Zhang M; Qiu C; Zhang Y; Du D; Niu B
    Biomed Res Int; 2017; 2017():4649191. PubMed ID: 28630865
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors.
    Balupuri A; Balasubramanian PK; Gadhe CG; Cho SJ
    SAR QSAR Environ Res; 2014; 25(8):651-71. PubMed ID: 24911214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling of p38 mitogen-activated protein kinase inhibitors using the Catalyst HypoGen and k-nearest neighbor QSAR methods.
    Xiao Z; Varma S; Xiao YD; Tropsha A
    J Mol Graph Model; 2004 Oct; 23(2):129-38. PubMed ID: 15363455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
    Jarapula R; Badavath VN; Rekulapally S; Manda S
    Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
    Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
    J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
    Qin J; Xi L; Du J; Liu H; Yao X
    Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probing the structural requirements of A-type Aurora kinase inhibitors using 3D-QSAR and molecular docking analysis.
    Zhang HX; Li Y; Wang X; Wang YH
    J Mol Model; 2012 Mar; 18(3):1107-22. PubMed ID: 21670994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors.
    Qin X; Yang L; Liu P; Yang L; Chen L; Hu L; Jiang M
    Bioorg Chem; 2021 May; 110():104743. PubMed ID: 33714020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insights into the EGFR SAR of N-phenylquinazolin-4-amine-derivatives using quantum mechanical pairwise-interaction energies.
    Simeon S; Jongkon N; Chotpatiwetchkul W; Gleeson MP
    J Comput Aided Mol Des; 2019 Aug; 33(8):745-757. PubMed ID: 31494804
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.
    Tintori C; Magnani M; Schenone S; Botta M
    Eur J Med Chem; 2009 Mar; 44(3):990-1000. PubMed ID: 18722033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.